Jiří Laštůvka
Jiří Laštůvka publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Atrial Fibrillation Management and Outcomes, Lipoproteins and Cardiovascular Health and Venous Thromboembolism Diagnosis and Management.
- World rank
- #1,457,519 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #112,425 of 367,258
- Works
- 22
- Citations
- 2.4k
- Citations per work
- 107.9
What does Jiří Laštůvka research?
Jiří Laštůvka's work is mostly in Medicine (83%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1883.3%
- Medicine1883.3%
- Everything else416.7%
- 1Cardiology and Cardiovascular Medicine33% of their works
- 2Surgery17% of their works
- 3Endocrinology, Diabetes and Metabolism15% of their works
- 4Internal Medicine8% of their works
- 5Rheumatology7% of their works
- 6Nephrology3% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Lipoproteins and Cardiovascular Health
- Venous Thromboembolism Diagnosis and Management
- Diabetes Treatment and Management
- Rheumatoid Arthritis Research and Therapies
- Blood Pressure and Hypertension Studies
- Cardiovascular Disease and Adiposity
- Lipid metabolism and disorders
Which keywords describe Jiří Laštůvka's research?
The keywords of their largest research topics: Anticoagulant Therapy, Atrial Fibrillation, Risk Factors, Cholesterol-lowering, Clinical Guidelines, Statins, Antithrombotic Therapy and Inflammation.
- Lipoprotein Lipase
- Epicardial Fat
- ANGPTL3
- Biological Therapy
- Cardiovascular Outcomes
- Atherosclerosis
- Inflammation
- Statins
- Cholesterol-lowering
- Atrial Fibrillation
- Anticoagulant Therapy
- Risk Factors
- Clinical Guidelines
- Antithrombotic Therapy
- Venous Thromboembolism
- Cardiovascular Disease
- Type 2 Diabetes
- Rheumatoid Arthritis
- Blood Pressure
- Hypertension
- Perivascular Adipose Tissue
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Anticoagulant Therapy81 topic
- Atrial Fibrillation81 topic
- Risk Factors72 topics
- Cholesterol-lowering61 topic
- Clinical Guidelines62 topics
- Statins61 topic
- Antithrombotic Therapy51 topic
- Inflammation52 topics
- Venous Thromboembolism51 topic
- Atherosclerosis42 topics
- Cardiovascular Disease42 topics
- Cardiovascular Outcomes41 topic
- Type 2 Diabetes41 topic
- Biological Therapy31 topic
- Rheumatoid Arthritis31 topic
- ANGPTL321 topic
- Blood Pressure21 topic
- Epicardial Fat21 topic
- Hypertension21 topic
- Lipoprotein Lipase21 topic
- Perivascular Adipose Tissue21 topic
Where does Jiří Laštůvka work?
Jiří Laštůvka's main affiliation in the publication record is Thrombosis Research Institute, United Kingdom.
How many publications and citations does Jiří Laštůvka have?
OpenAlex counts 22 works and 2,373 citations for Jiří Laštůvka, an h-index of 12, ranking #1,457,519 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jiří Laštůvka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.